These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2098984)

  • 21. [Clinical value of determining the levels of lupus anticoagulant and anti-cardiolipin antibodies].
    Alekberova ZS; Nasonov EL; Prudnikova LZ; Aleksandrova LZ; Kurdiashova VF
    Ter Arkh; 1988; 60(7):84-7. PubMed ID: 3145584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A methodological contribution on the function testing of human blood platelets under standard conditions].
    Gross R; Niemeyer G; Reuter H
    Dtsch Med Wochenschr; 1969 Aug; 94(35):1735-43. PubMed ID: 4980283
    [No Abstract]   [Full Text] [Related]  

  • 23. The endothelium and coagulopathy in systemic lupus erythematosus: hyperhomocysteinemia as a developing risk factor.
    Fijnheer R; Blann AD
    J Rheumatol; 2003 Jul; 30(7):1400-2. PubMed ID: 12858432
    [No Abstract]   [Full Text] [Related]  

  • 24. [Thrombocytic component of hemostasis in patients operated on for acute inflammatory diseases of the abdominal organs].
    Pchel'nikova EF; Petukhov IA; Ivanov EP
    Vestn Khir Im I I Grek; 1991 Feb; 146(2):31-6. PubMed ID: 1652831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Structural and functional bases of hemostasis and its pathology].
    Strukov AI; Strukova SM
    Arkh Patol; 1980; 42(9):3-16. PubMed ID: 7000046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating anticoagulant against factor XI and thrombocytopenia with platelet aggregation inhibition in systemic lupus erythematosus.
    Leone G; Accorra F; Boni P
    Acta Haematol; 1977; 58(4):240-5. PubMed ID: 410226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coagulation defects in a case of systemic lupus erythematosus with thrombocytopenia.
    BONNIN JA; COHEN AK; HICKS ND
    Br J Haematol; 1956 Apr; 2(2):168-79. PubMed ID: 13315902
    [No Abstract]   [Full Text] [Related]  

  • 28. [A histochemical evaluation of thrombocyte metabolism in systemic lupus erythematosus].
    Kozlovskaia NL; Artem'eva VB; Kuznetsov SL; Kabaenkova GS; Kozlovskaia LV
    Ter Arkh; 1994; 66(6):35-6. PubMed ID: 7940363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Results of a new platelet function test in various clinical diseases and in preserved blood].
    Frick U; Frick G; Förster HJ
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1978; 105(3):384-90. PubMed ID: 80366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood coagulation and platelet profiles in persistent post-splenectomy thrombocytosis. The relationship to thromboembolism.
    Visudhiphan S; Ketsa-Ard K; Piankijagum A; Tumliang S
    Biomed Pharmacother; 1985; 39(6):264-71. PubMed ID: 4084660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigations of the lupus-like inhibitor by-passing activity of platelets.
    Howard MA; Firkin BG
    Thromb Haemost; 1983 Dec; 50(4):775-9. PubMed ID: 6420922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Experiences with chromium labeling of thrombocytes].
    Mühlenen A; Gurtner HP; Bucher U
    Schweiz Med Wochenschr; 1966 Sep; 96(37):1206-9. PubMed ID: 5994843
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical importance of changes in thrombocytic hemostasis in lung cancer].
    Tulupov AN; Buravtsov VI; Kostiuchenko AL; Grishakov SV; Bel'skikh AN
    Vestn Khir Im I I Grek; 1987 Apr; 138(4):7-10. PubMed ID: 3629853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monoclonal immunoglobulin M lambda coagulation inhibitor with phospholipid specificity. Mechanism of a lupus anticoagulant.
    Thiagarajan P; Shapiro SS; De Marco L
    J Clin Invest; 1980 Sep; 66(3):397-405. PubMed ID: 6772673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [DNAse II from phagocytes in the study of the pathogenesis of systemic lupus erythematosus].
    Matul'skaia LI; Klimov VIu; Riazantseva TA; Pleskovskaia GN
    Vopr Med Khim; 1986; 32(1):32-4. PubMed ID: 3953009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of low-intensity warfarin on coagulation activation in patients with antiphospholipid antibodies and systemic lupus erythematosus.
    Douketis JD; Crowther MA; Julian JA; Stewart K; Donovan D; Kaminska EA; Laskin CA; Ginsberg JS
    Thromb Haemost; 1999 Sep; 82(3):1028-32. PubMed ID: 10494759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Circulating anticoagulants with antiprothrombinase activity in systemic lupus erythematosus (author's transl)].
    Gazengel C; Dougados M; Kremp O; Tron F; Noël LH; Jungers P
    Nouv Presse Med; 1980 Sep; 9(33):2325-8. PubMed ID: 7433022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hemorrhagic diathesis caused by platelet function disorders in systemic lupus erythematosus].
    Kreps Z; Czestochowska E
    Pol Tyg Lek; 1979 Feb; 34(8):303-4. PubMed ID: 441044
    [No Abstract]   [Full Text] [Related]  

  • 39. Haemostatic abnormalities in systemic lupus erythematosus.
    Gladman DD; Urowitz MB; Tozman EC; Glynn MF
    Q J Med; 1983; 52(207):424-33. PubMed ID: 6647751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The circulating anticoagulant in disseminated lupus erythematosus.
    PERKINS HA; ACRA DJ
    Thromb Diath Haemorrh; 1960 Dec; 5():250-5. PubMed ID: 13734398
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.